Inhibitor Therapeutics holders back board, pay
INTI’s 2026 annual meeting approved all management proposals, including director elections, auditor ratification, incentive plan and executive pay.
Rhea-AI Filing Summary
Inhibitor Therapeutics, Inc. (INTI) reported the results of its 2026 Annual Meeting of Stockholders held on September 15, 2026. Stockholders elected six directors — Francis E. O’Donnell, Samuel J. Sears, Niraj Vasisht, Michelle Yanez, Michael Jerman and Ronald E. Osman — each to serve a one-year term expiring at the 2027 annual meeting.
Stockholders ratified the appointment of Cherry Bekaert LLP as independent registered public accounting firm for the year ending December 31, 2026. They also approved the 2025 Share Incentive Plan, and, in a non-binding advisory vote, approved the Company’s executive compensation. In addition, stockholders indicated a preferred frequency of future say-on-pay votes of both one year and three years, with the largest support for a three-year frequency.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.02, 5.07
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes For – most director nominees: 96,676,056 votes
Votes For – Michelle Yanez and Michael Jerman: 98,342,951 votes
Auditor ratification Votes For: 110,776,019 votes
+4 more
7 metrics
Votes For – most director nominees
96,676,056 votes
Support for director nominees Francis E. O’Donnell, Samuel J. Sears, Niraj Vasisht and Ronald E. Osman
Votes For – Michelle Yanez and Michael Jerman
98,342,951 votes
Support for director nominees Michelle Yanez and Michael Jerman
Auditor ratification Votes For
110,776,019 votes
Ratification of Cherry Bekaert LLP for fiscal year ending December 31, 2026
Share Incentive Plan Votes For
96,249,721 votes
Approval of the 2025 Share Incentive Plan
Say-on-Pay Votes For
96,854,767 votes
Non-binding advisory vote approving executive compensation
Say-on-Pay Frequency – 1 year support
22,443,829 votes
Advisory vote for annual say-on-pay frequency
Say-on-Pay Frequency – 3 year support
76,086,572 votes
Advisory vote for triennial say-on-pay frequency
Key Terms
broker non-votes, non-binding advisory vote, independent registered public accounting firm, Share Incentive Plan, +1 more
5 terms
broker non-votes financial
"Director Nominee | | Votes For | | Withheld | | Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
non-binding advisory vote financial
"The Company’s executive compensation, by non-binding advisory vote, was approved."
A non-binding advisory vote is a shareholder vote that expresses investors’ opinion on a proposal (such as executive pay, corporate policy, or governance practices) but does not legally force the company to act. Think of it like a customer survey: it signals whether owners approve or disapprove and can pressure boards and managers to change course, so investors watch the result as an indicator of governance risk and potential future shifts in company strategy or leadership.
independent registered public accounting firm financial
"as the Company’s independent registered public accounting firm for the fiscal year"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
frequency of future non-binding advisory votes financial
"indicated, on an advisory basis, the preferred frequency of future non-binding"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did INTI stockholders vote on at the 2026 Annual Meeting?
Stockholders voted on director elections, auditor ratification, approval of the 2025 Share Incentive Plan, a say-on-pay advisory vote on executive compensation, and the frequency of future say-on-pay votes.
Which directors were elected to the INTI board in 2026 and for how long?
Stockholders elected Francis E. O’Donnell, Samuel J. Sears, Niraj Vasisht, Michelle Yanez, Michael Jerman and Ronald E. Osman to the Board for one-year terms expiring at the 2027 Annual Meeting.
Did INTI (symbol INTI) stockholders ratify the company’s auditor for 2026?
Yes. Stockholders ratified Cherry Bekaert LLP as Inhibitor Therapeutics, Inc.’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with 110,776,019 votes for, 1,668,434 against and 1,501 abstentions.
How did INTI stockholders vote on executive compensation in 2026?
Executive compensation was approved in a non-binding advisory say-on-pay vote, receiving 96,854,767 votes for, 2,605,058 against, 101 abstentions and 12,986,028 broker non-votes.
What frequency of say-on-pay votes did INTI stockholders prefer?
Stockholders indicated a preference for say-on-pay votes with 22,443,829 votes for 1 year, 10,501 for 2 years, 76,086,572 for 3 years, 919,024 abstentions and 12,986,028 broker non-votes, with the largest support for a three-year frequency.
AI-generated analysis. How Rhea-AI works. Not financial advice.
